REQUEST A DEMO
Total
USD $0.00
Search more companies

Napar Pharmachem Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Napar Pharmachem Private Limited Profile Updated: March 06, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Napar Pharmachem Private Limited is based in India. The head office is in Thane. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The enterprise was incorporated on August 14, 2013. The company’s latest financial report indicates a net sales revenue increase of 2.68% in 2025. Its’ total assets recorded a growth of 12.71%. The enterprise’s net profit margin increased by 0.11% in 2025.

Legal Address
Plot No. 37, Office No. 705, Sai Enterprises (Skylon Towers)Sector 19A, Apmc, Vashi
Thane; Maharashtra; Postal Code: 400703

Contact Details: Purchase the Napar Pharmachem Private Limited report to view the information.

Basic Information
Registered Capital:
Purchase the Napar Pharmachem Private Limited report to view the information.
Financial Auditors:
Purchase the Napar Pharmachem Private Limited report to view the information.
Incorporation Date:
August 14, 2013
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Company Performance
Financial values in the chart are available after Napar Pharmachem Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
2.68%
Total Operating Revenue
3.79%
Operating Profit
7.25%
EBITDA
8.83%
Net Profit/Loss for the Period
6.92%
Total Assets
12.71%
Total Equity
48.72%
Operating Profit Margin
0.18%
Net Profit Margin
0.11%
Return on Equity (ROE)
-12.81%
Debt / Equity
7%
Quick Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?